TIKOMED AB
556622-8960ActiveDeveloping novel drug candidates for neurodegenerative diseases via partnerships.
Biotechnology / Investment Holding Companytikomed.com
Yleiskatsaus
- 1–4
- Työntekijät
- 10–20milj SEK
- Liikevaihto
- 2002
- Perustettu
Avainpäättäjät
Lars Bruce
Founder and Lead of ILB Program
Göran Groth
Chairman of the Board
Christian Treschow
Chairman
Björn Pilström
Chief Executive Officer and Chief Medical Officer
+9 lisää yhteystietoja Funnelfeedrissä
Kuvaus
TikoMed AB is a privately owned Swedish company established in 2002, focused on groundbreaking scientific innovation in drug development. The core of their work revolves around developing ILB®, a novel molecule demonstrating unique properties in stimulating the body’s natural repair mechanisms. This...